TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2021

Excellent Outcome for Pediatric Patients With High-Risk Hodgkin Lymphoma Treated With Brentuximab Vedotin and Risk-Adapted Residual Node Radiation.

Monika L Metzger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.